Thiomersal in vaccines: A regulatory perspective - WHO Consultation, Geneva, 15-16 April 2002

Vaccine

Volumn 22, Issue 15-16, 2004, Pages 1836-1841

  Knezevic, I ^a   Griffiths, E ^b   Reigel, F ^c   Dobbelaer, R ^d  

^a WORLD HEALTH ORGANIZATION   (Switzerland)

^b HEALTH CANADA   (Canada)

^c Swissmedic   (Switzerland)

^d SCIENTIFIC INSTITUTE OF PUBLIC HEALTH   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

2 PHENOXYETHANOL; DIPHTHERIA PERTUSSIS TETANUS VACCINE; HEPATITIS B VACCINE; INFLUENZA VACCINE; RECOMBINANT DNA; THIOMERSAL; TICK BORNE ENCEPHALITIS VACCINE; VACCINE;

ACTIVE IMMUNIZATION; CLINICAL TRIAL; CONFERENCE PAPER; DRUG APPROVAL; DRUG EFFICACY; DRUG FORMULATION; DRUG QUALITY; DRUG SAFETY; FEVER; HUMAN; POSTMARKETING SURVEILLANCE; PRIORITY JOURNAL; SIDE EFFECT; TOXICITY; WORLD HEALTH ORGANIZATION;

ENCEPHALITIS VIRUSES, TICK-BORNE; EUROPE; LEGISLATION, DRUG; PRESERVATIVES, PHARMACEUTICAL; THIMEROSAL; UNITED STATES; VACCINES;

EID: 2342455203     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2003.11.051     Document Type: Conference Paper

References (13)

1. Halsey N.A. Limiting infant exposure to thimerosal in vaccines and other sources of mercury. J. Am. Med. Assoc. 282:1999;1763-1766
2. Clements C.J., Ball L.K., Ball R., Pratt D. Thiomersal in vaccines. Lancet. 355:2000;1279-1280
3. Pless R. Mercury, infant neurodevelopment, and vaccination. J. Pediatr. 136:2000;571-573
4. Stajich G.V., Lopez G.P., Harry S.W., Sexson W.R. Iatrogenic exposure to mercury after hepatitis B vaccination in preterm infants. J. Pediatr. 136:2000;679-681
5. WHO. Thiomersal as a vaccine preservative. Wkly Epidemiol Rec 2000;75:12-6.
6. Ball L.K., Ball R., Pratt R.D. An assessment of thimerosal use in childhood vaccines. Pediatric. 107:2001;1147-1154
7. WHO Policy Statement: the use of opened multi-dose vials of vaccine in subsequent immunization sessions. 2000. WHO/V&B/00.09.
8. WHO. Vaccines and biologicals: recommendations from the Strategic Advisory Group of Experts. Wkly Epidemiol Rec 2002;77:306.
9. WHO. Safety of thiomersal. Global Advisory Committee on Vaccine Safety. Wkly Epidemiol Rec 2002;77:390.
10. CPMP/BWP/2517/00: points to consider on the reduction, elimination or substitution of thiomersal in vaccines. May 2001.
11. European Commission Regulations No. 541/95, 542/95, 1146/98 and 1069/98.
12. Modifica della composizione di medicinali constituti da vaccini monodose iniettabili contenenti mertiolato o altri composti organomercuriali come conservanti o come residui nel processo di fabbricazione. Gazzetta Ufficiale della Repubblica Italiana, serie generale, no. 66 del 19 Marzo 2002. Ministero della salute, Decreto 13 Novembre 2001.
13. The Drugs & Cosmetic Act. 1940 and rules thereunder (official publication of Government of India).